Biotech Touched New Lows: Celladon (NASDAQ:CLDN), MediciNova (NASDAQ:MNOV), Mediwound (NASDAQ:MDWD), Celsion Corporation (NASDAQ:CLSN)

Celladon Corporation (NASDAQ:CLDN) was a big mover last session, as its shares rose nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the healthcare company since March 24, as the stock is down nearly 25%. Celladon Corp (NASDAQ:CLDN) stock performance was -7.72% in last session and finished the day at $9.21. Traded volume was 79,275.00million shares in the last session and the average volume of the stock remained 166.49K shares. Celladon Corp (NASDAQ:CLDN) insider ownership is 28.00%.

On March 28, 2014 (Japanese Standard Time), MediciNova, Inc. (NASDAQ:MNOV) filed with the Tokyo Stock Exchange a Japanese report referred to as “Kessan Tanshin,” which contained the Company’s financial results for the year ended December 31, 2013 (the “Tanshin”). MediciNova Inc. (NASDAQ:MNOV) dropped -7.84 percent to $1.88 Monday on volume of 199,225.00million shares. The intra-day range of the stock was $1.86 to $2.13. MediciNova, Inc. (NASDAQ:MNOV) has a market capitalization of $42.11million.

The American-Israeli retailer support startup Borderfree and the biotechnology company MediWound Ltd (NASDAQ:MDWD) both wrapped up successful flotations in New York this month, but website builder Wix this week withdrew a planned secondary offering. Mediwound Ltd (NASDAQ:MDWD)’s stock on Apr 07, 2014 reported a decrease of -10.00% to the closing price of $11.52. Its fifty two weeks range is $11.10 -$19.31. The total market capitalization recorded $235.00million. The overall volume in the last trading session was 291.572.00million shares. In its share capital, MDWD has 20.35million outstanding shares.

Celsion Corporation (NASDAQ:CLSN) issued a press release reported its financial results for the year ended December 31, 2013. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. On Monday, shares of Celsion Corporation (NASDAQ:CLSN) dropped -4.14% to close the day at $3.24. Company monthly performance is recorded as -18.39%. Celsion Corporation (NASDAQ:CLSN) quarterly revenue growth is -17.56%.